Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2010
04/22/2010US20100099726 Inhibitors of pyruvate kinase and methods of treating disease
04/22/2010US20100099713 2-aminopyridine derivatives as glucokinase activators
04/22/2010US20100099712 Substituted pyrazoline compounds with acat inhibition activity
04/22/2010US20100099694 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
04/22/2010US20100099691 Pyrimidinyl pyridone inhibitors of jnk
04/22/2010US20100099690 Xanthine derivatives as selective hm74a agonists
04/22/2010US20100099689 Methods of modulating ppar gamma-type receptors
04/22/2010US20100099678 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
04/22/2010US20100099671 Glucokinase activator
04/22/2010US20100099662 Hydrazone derivative
04/22/2010US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity
04/22/2010US20100099641 Crystalline form of 1-choloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
04/22/2010US20100099633 Method for enhancing nutrient absorption with astragalosides
04/22/2010US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
04/22/2010US20100099620 Protracted GLP-1 Compositions
04/22/2010US20100099619 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
04/22/2010US20100099615 Pancreatic regenerating protein i in chronic pancreatitis and aging implications for new therapeutic approaches to diabetes
04/22/2010US20100098793 Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing adiponectin levels
04/22/2010US20100098778 Compositions and Methods for Controlling The Weight of Animals
04/22/2010US20100098680 Anti-pathogen treatments
04/22/2010US20100098638 RIP140 Regulation of Diabetes
04/22/2010DE102008051834A1 Drug, useful e.g. for treating diabetes, preferably type-I or II and for controlling fasting, postprandial and/or postabsorptive plasma glucose concentration, comprises insulin and glucagon-like peptide-1 agonist
04/22/2010CA2805888A1 Whey protein compostions, methods and uses
04/22/2010CA2740316A1 Conjugates of glp-1 agonists and uses thereof
04/22/2010CA2739888A1 Spirocyclic gpr40 modulators
04/22/2010CA2739545A1 Method of determining a phosphorus binder dosage for a dialysis patient
04/22/2010CA2739490A1 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
04/22/2010CA2739466A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
04/22/2010CA2739060A1 Fused-ring derivative and medical application of same
04/22/2010CA2738872A1 New benzimidazole derivatives
04/22/2010CA2738367A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
04/21/2010EP2177530A1 Octapeptide having antiangiogenic activity
04/21/2010EP2177529A1 Novel -secretase inhibitor
04/21/2010EP2176265A1 Imidazo [1, 2-c]pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists
04/21/2010EP2176258A1 Piperidine derivatives useful as orexin receptor antagonists
04/21/2010EP2176255A1 Andrographolide derivatives and use thereof in manufacture of medicaments
04/21/2010EP2176251A2 5-pyridinone substituted indazoles
04/21/2010EP2176250A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
04/21/2010EP2175853A1 Methods of treating metabolic syndrome using dopamine receptor agonists
04/21/2010EP2175852A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
04/21/2010EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/21/2010EP0910369B1 Benzothiophenes, formulations containing same, and methods
04/21/2010CN1947737B Application of psammophytes strawflower total saponin in preparing medicine
04/21/2010CN1931269B Rutin containing medicine composition
04/21/2010CN1891296B Medicinal composition containing calcium agonist and phenoxy acid compound
04/21/2010CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same
04/21/2010CN1823604B Seaweed tea and its preparation method
04/21/2010CN1689628B Medical purpose of creat extract
04/21/2010CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes
04/21/2010CN1514725B Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester
04/21/2010CN101696386A Highland barley monascus healthy wine and brewing method thereof
04/21/2010CN101696228A N-pyrazolyl glycosides derivatives as well as preparation method and application thereof
04/21/2010CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
04/21/2010CN101695575A Pharmaceutical composition containing statin-type lipid-lowering medicaments, phenformin-type hypoglycemic medicaments and nicotinic acid
04/21/2010CN101695552A Chinese medicinal composition capable of strengthening stomach and promoting growth of livestock and preparation method thereof
04/21/2010CN101695533A Chinese medicinal composition for decreasing blood glucose
04/21/2010CN101695528A Medicament for purifying blood
04/21/2010CN101695520A Preparation method of medicament for treating diabetes
04/21/2010CN101695507A Medicament for treating diabetes
04/21/2010CN101695491A Slow-release preparation of repaglinide
04/21/2010CN101695487A Polyenoic ethyl ester emulsion of high-purity EPA-E and DHA-E
04/21/2010CN101695482A Glipizide orally disintegrating tablet and preparation process thereof
04/21/2010CN101695481A Mitiglinide calcium dispersible tablet and preparation method thereof
04/21/2010CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/21/2010CN101366882B Compound formulation with function of reducing blood fat and blood sugar
04/21/2010CN101357132B Composition for treating hyperlipemia
04/21/2010CN101156847B Usage of purplish plastocyanin as insulin sensitization agent
04/21/2010CN101125154B Raidx cynanchum bungei decne glycoside of mountain Tai and preparation method thereof
04/21/2010CN101041652B Separating purified new bisflavone compound from dragon's blood and preparation method thereof
04/21/2010CN101032599B Healthy solution for conditioning skin and losing weight
04/21/2010CN101018846B Method for producing unsaturated fatty acid concentrate
04/21/2010CN100998626B Method for preparing extract of korea thistle leaf
04/20/2010US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/20/2010US7700657 Vitamin D analogs
04/20/2010US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's
04/20/2010US7700595 such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs)
04/20/2010US7700583 11β-hydroxysteroid dehydrogenase type 1 active compounds
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700549 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence
04/20/2010US7700361 Secretory or membrane protein expressed in skeletal muscles
04/20/2010US7700087 Compounds and methods to inhibit or augment an inflammatory response
04/20/2010US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing
04/20/2010CA2581865C Indazolone derivatives as 11b-hsd1 inhibitors
04/20/2010CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
04/20/2010CA2495146C Oil composition
04/20/2010CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
04/20/2010CA2447926C Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
04/20/2010CA2438506C Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
04/20/2010CA2433335C Particles for inhalation having sustained release properties
04/20/2010CA2426764C Nateglinide-containing hydrophilic pharmaceutical preparation
04/20/2010CA2421058C Protein hydrolysates produced with the use of marine proteases
04/20/2010CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives
04/20/2010CA2418744C Novel aminocyclohexane derivatives
04/20/2010CA2408528C Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
04/20/2010CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents
04/20/2010CA2352572C Humanized antibodies to gamma-interferon
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2155303C Treatment for insulin dependent diabetes
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 1298